Fenwick & West has advised Attovia Therapeutics. Cooley LLP has advised the underwriters. Attovia Therapeutics, a clinical-stage biopharmaceutical company, has announced the pricing of its upsized...
Attovia Therapeutics Launches Upsized $289 Million Initial Public Offering
Scribe Therapeutics Completes $155.51 Million Initial Public Offering and Private Placement
Fenwick has advised Scribe Therapeutics. Latham & Watkins has advised the underwriters. Scribe Therapeutics Inc., a clinical-stage biotechnology company specializing in in vivo CRISPR technologies, has...
Lycia Therapeutics Secures $75 Million in Series D Financing
Fenwick & West has advised Lycia Therapeutics. Lycia Therapeutics, a clinical-stage biotechnology company, has completed a $75 million Series D financing round. The funding round was...
Remix Therapeutics and Passage Bio Announce Merger and $100 Million Private Placement
Latham & Watkins LLP has advised Remix Therapeutics. Fenwick & West LLP has advised Passage Bio. Cooley LLP has advised Goldman Sachs & Co. LLC, Jefferies...
Merger Agreement Between Treeline Biosciences and Standard BioTools
Freshfields LLP and Richards, Layton & Finger, P.A. have advised Standard BioTools. Fenwick & West LLP has represented Treeline Biosciences. Treeline Biosciences and Standard BioTools Inc....
Servier to Acquire Day One Biopharmaceuticals in $2.5 Billion Transaction
Baker McKenzie has advised Servier, and Fenwick & West has advised Day One Biopharmaceuticals. Wilson Sonsini Goodrich & Rosati advised Day One on IP matters related...
Halozyme Acquires Surf Bio in $400 Million Deal to Expand Drug Delivery Capabilities
Fenwick & West has advised Surf Bio on the deal. Surf Bio, a biopharmaceutical company specializing in innovative drug delivery technologies, has been acquired by Halozyme...
Caldera Therapeutics Launches with $112.5 Million to Advance Bispecific Antibody for IBD
Fenwick & West has advised Caldera Therapeutics. Caldera Therapeutics, a clinical-stage biotechnology company, has secured $112.5 million in funding to support the development of its bispecific...
EpiBiologics Secures $107 Million in Series B Funding to Advance Antibody Pipeline
Fenwick & West has advised EpiBiologics. EpiBiologics, a company specializing in tissue-selective extracellular protein degradation, has completed a $107 million Series B financing round. The funding...
Day One Biopharmaceuticals to Acquire Mersana Therapeutics in Transaction Valued Up to $285 Million
Wilmer Cutler Pickering Hale and Dorr has advised Mersana Therapeutics. Fenwick & West has advised Day One Biopharmaceuticals. Wilson Sonsini Goodrich & Rosati advised Day One...
Maze Therapeutics Announces $150 Million Private Placement
Fenwick & West has advised Maze Therapeutics. Maze Therapeutics, a clinical-stage biopharmaceutical company, has announced the signing of a securities purchase agreement for an oversubscribed private...
Maze Therapeutics’ $140 Million Upsized Initial Public Offering
Fenwick & West represented Maze Therapeutics in the offering, and Davis Polk & Wardwell represented the underwriters. Maze Therapeutics, Inc. (Nasdaq: MAZE) announced its upsized initial...